Literature DB >> 10668642

Enhanced platelet aggregation, high homocysteine level, and microvascular disease in diabetic muscle infarctions: implications for therapy.

V Rajkumar1, P Ragatzki, A Sima, J Levy.   

Abstract

Muscle infarction is a rare complication in patients with diabetes mellitus, probably because of the rich vascular supply of this tissue. We describe a patient with type 1 diabetes who had infarction of the muscles in her right thigh. We report, for the first time, that the patient, in addition to an advanced microvascular disease in the muscle, had increased plasma total homocysteine levels and increased platelet aggregation. These pathologies might have a synergistic effect on the development of this rare complication and should be treated aggressively to prevent further episodes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668642     DOI: 10.1385/endo:11:1:57

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  14 in total

1.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-1997. A 54-year-old diabetic woman with pain and swelling of the leg.

Authors: 
Journal:  N Engl J Med       Date:  1997-09-18       Impact factor: 91.245

2.  Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes.

Authors:  E Okada; K Oida; H Tada; K Asazuma; K Eguchi; G Tohda; S Kosaka; S Takahashi; I Miyamori
Journal:  Diabetes Care       Date:  1999-03       Impact factor: 19.112

3.  Clinical and radiologic features of spontaneous muscle infarction in the diabetic.

Authors:  S Reich; S N Wiener; S Chester; R Ruff
Journal:  Clin Nucl Med       Date:  1985-12       Impact factor: 7.794

4.  MRI diagnosis of diabetic muscle infarction: report of two cases.

Authors:  N J Khoury; G Y el-Khoury; M H Kathol
Journal:  Skeletal Radiol       Date:  1997-02       Impact factor: 2.199

5.  Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.

Authors:  M A Hofmann; B Kohl; M S Zumbach; V Borcea; A Bierhaus; M Henkels; J Amiral; W Fiehn; R Ziegler; P Wahl; P P Nawroth
Journal:  Diabetes Care       Date:  1997-12       Impact factor: 19.112

6.  Diabetic muscle infarction: a new perspective on pathogenesis and management.

Authors:  E K Bjornskov; M R Carry; F H Katz; J Lefkowitz; S P Ringel
Journal:  Neuromuscul Disord       Date:  1995-01       Impact factor: 4.296

7.  Skeletal muscle infarction in diabetes: MR findings.

Authors:  M Nuñez-Hoyo; C L Gardner; A O Motta; J W Ashmead
Journal:  J Comput Assist Tomogr       Date:  1993 Nov-Dec       Impact factor: 1.826

Review 8.  Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis.

Authors:  D Tschoepe; P Roesen; B Schwippert; F A Gries
Journal:  Semin Thromb Hemost       Date:  1993       Impact factor: 4.180

Review 9.  Platelet abnormalities in diabetes mellitus.

Authors:  A B Glassman
Journal:  Ann Clin Lab Sci       Date:  1993 Jan-Feb       Impact factor: 1.256

10.  Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease.

Authors:  M N Munshi; A Stone; L Fink; V Fonseca
Journal:  Metabolism       Date:  1996-01       Impact factor: 8.694

View more
  4 in total

1.  Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia.

Authors:  J Liu; Y Xu; H Zhang; X Gao; H Fan; G Wang
Journal:  J Hum Hypertens       Date:  2014-03-27       Impact factor: 3.012

2.  X-ray imaging of differential vascular density in MMP-9-/-, PAR-1-/+, hyperhomocysteinemic (CBS-/+) and diabetic (Ins2-/+) mice.

Authors:  S Givvimani; U Sen; N Tyagi; C Munjal; S C Tyagi
Journal:  Arch Physiol Biochem       Date:  2010-09-14       Impact factor: 4.076

Review 3.  Retrospective analysis of treatment modalities in diabetic muscle infarction.

Authors:  Ikenna Onyenemezu; Eugenio Capitle
Journal:  Open Access Rheumatol       Date:  2014-01-10

4.  Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress.

Authors:  Hossam Ebaid; Samir A E Bashandy; Ahmad M Abdel-Mageed; Jameel Al-Tamimi; Iftekhar Hassan; Ibrahim M Alhazza
Journal:  Nutr Metab (Lond)       Date:  2020-01-14       Impact factor: 4.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.